Janio Szklaruk, M.D., Ph.D.
Department of Abdominal Imaging, Division of Diagnostic Imaging
About Dr. Szklaruk
Dr. Janio Szklaruk earned his medical degree from the University of Pennsylvania School of Medicine and completed his residency at Thomas Jefferson University Hospital. He joined MD Anderson Cancer Center (MDACC) in October 2000. Before joining MDACC, he served as an Assistant Professor of Radiology at Hahnemann University Hospital in Philadelphia, PA. Dr. Szklaruk has been an educator at numerous national and international conferences, including refresher courses and workshops at the Radiological Society of North America (RSNA) and the Society of Abdominal Radiology.
He has published extensively on oncologic imaging, with articles appearing in journals such as Radiology, AJR, PLOS ONE, JCAT, J Hepatocellular Cancer, and Abdominal Imaging. Additionally, he has co-authored multiple book chapters and edited a section of a textbook on oncologic imaging.
Dr. Szklaruk has been invited to speak at national and international conferences, including events in Colombia, Cuba, Brazil, Ecuador, Peru, Puerto Rico, Chile, Argentina, and Israel. His research interests focus on the application of new MR imaging techniques and contrast agents in oncologic imaging. He served as Co-Chief, ad interim, of the Abdominal Imaging (AI) section from September 2016 to January 2018 and was Chief of Abdominal Imaging MR from 2014 to 2022.
Present Title & Affiliation
Primary Appointment
Professor, Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, McGovern Medical School at Houston, Houston, TX
Research Interests
Evaluation of new MR techniques.
MRI in the evaluation of liver lesions and liver pathology.
Clinical Interests
CT and MR of hepatobiliary tumors.
Education & Training
Degree-Granting Education
1993 | University of Pennsylvania School of Medicine, Philadelphia, PA, USA, MD, Medicine |
1989 | State University of New York at Stony Brook, Stony Brook, NY, USA, PHD, Physical Chemistry |
1984 | Brandeis University, Waltham, MA, USA, MA, Physical Chemistry |
1982 | University of Puerto Rico, Rio Piedras, PR, USA, BS, Chemistry |
Board Certifications
1998 | American Board of Radiology, Diplomat of the American Board of Radiology |
1994 | National Board of Medical Examiners, Diplomat of the National Board of Medical Examiners |
Experience & Service
Academic Appointments
Associate Professor, Department of Diagnostic and Interventional Imaging, McGovern Medical School at Houston, Houston, TX, 2019 - 2023
Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2019
Associate Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2011
Associate Professor, Division of Diagnostic and Interventional Imaging, The University of Texas Health Science Center, Medical School, Houston, TX, 2006 - 2019
Administrative Appointments/Responsibilities
Section Co-Chair ad interim, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2018
MRI Director, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2022
Institutional Committee Activities
Member, CFRC -Promotion Committee of Institution, 2023 - Present
Member, CABI MR Operations Committee, 2016 - 2022
Member, ECFS, 2015 - 2022
Abdominal Imaging Representative, MR- Safety Committee, 2014 - 2022
Member, AI-Clinical Operation Committee, 2014 - Present
Director, MRI - Abdominal Radiology, 2014 - 2022
Co-Chair, MR Quality Assurance Body Imaging Review Committee, 2005 - 2022
Member, Body MRI Protocol Development Committee, 2003 - 2022
Member, MRI Utilization Committee, 2002 - 2022
Member, Liver Conference Program Planning Committee, 2001 - 2022
Honors & Awards
2023 | Fellow, American College of Radiology |
2020 | Top Download Paper 2018-2019, Journal of Magnetic Resonance Imaging |
2016 | Cum Laude, Focal hepatic lesions; pitfalls, pseudolesions and misdiagnoses, Radiological Society of North America |
2015 | Health Information Resource Center Award, Patient Education's, Magnetic resonance imaging: the patient experience, Merit, Magnetic Resonance Imaging: The Patient Experience |
2014 | Celebrating Improvement, MD Anderson Cancer Center |
2014 | Celebrating Improvement, MD Anderson Cancer Center |
2014 | Certificate, AUR Radiology Management Program |
2013 | Award of Finalist, Society of Computed Body Tomography & Magnetic Resonance |
2013 | Award of Finalist, Society of Computed Body Tomography & Magnetic Resonance |
1982 | Magna Cum Laude, The University of Puerto Rico |
1982 | Dean's List, The University of Puerto Rico |
1978 | Honor Program of the National Science Foundation, Minority Access to Research Careers |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Chang E, Wong FCL, Chasen BA, Erwin WD, Das P, Holliday EB, Koong AC, Ludmir EB, Minsky BD, Noticewala SS, Smith GL, Taniguchi CM, Rodriguez MJ, Beddar S, Martin-Paulpeter RM, Niedzielski JS, Sawakuchi GO, Schueler E, Perles LA, Xiao L, Szklaruk J, Park PC, Dasari AN, Kaseb AO, Kee BK, Lee SS, Overman MJ, Willis JA, Wolff RA, Tzeng CD, Vauthey JN, Koay EJ. Phase I trial of single-photon emission computed tomography-guided liver-directed radiotherapy for patients with low functional liver volume. JNCI Cancer Spectr 8(3):pkae037, 2024. e-Pub 2024. PMID: 38730548.
- Moawad AW, Morshid A, Khalaf AM, Elmohr MM, Hazle JD, Fuentes D, Badawy M, Kaseb AO, Hassan M, Mahvash A, Szklaruk J, Qayyum A, Abusaif A, Bennett WC, Nolan TS, Camp B, Elsayes KM. Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation. Sci Data 10(1):33, 2023. e-Pub 2023. PMID: 36653372.
- Saleh M, Virarkar M, Javadi S, Mathew M, Vulasala SSR, Son JB, Sun J, Bayram E, Wang X, Ma J, Szklaruk J, Bhosale P. A feasibility study on deep learning reconstruction to improve image quality with PROPELLER acquisition in the setting of T2-weighted gynecologic pelvic magnetic resonance imaging. J Comput Assist Tomogr 47(5):721-728, 2023. e-Pub 2023. PMID: 37707401.
- Virarkar M, Szklaruk J, Diab R, Bassett R, Bhosale P. Diagnostic value of 3.0 T versus 1.5 T MRI in staging prostate cancer: systematic review and meta-analysis. Pol J Radiol 87:e421-e429, 2022. e-Pub 2022. PMID: 35979151.
- Virarkar M, Szklaruk J, Jensen CT, Taggart MW, Bhosale P. What's new in hepatic steatosis. Semin Ultrasound CT MR 42(4):405-415, 2021. e-Pub 2021. PMID: 34130852.
- Morshid A, Szklaruk J, Yacoub JH, Elsayes KM. Errors and misinterpretations in imaging of chronic liver diseases. Magn Reson Imaging Clin N Am 29(3):419-436, 2021. PMID: 34243927.
- Wang X, Ma J, Bhosale P, Ibarra Rovira JJ, Qayyum A, Sun J, Bayram E, Szklaruk J. Novel deep learning-based noise reduction technique for prostate magnetic resonance imaging. Abdom Radiol (NY) 46(7):3378-3386, 2021. e-Pub 2021. PMID: 33580348.
- Bitar R, Szklaruk J, Martiniova L, Zurita AJ, Chery LJ, Ravizzini G. 18F-Fluciclovine uptake in a ureterocele. Clin Nucl Med 46(1):e3-e5, 2021. e-Pub 2020. PMID: 32956112.
- Saleh M, Virarkar M, Bura V, Valenzuela R, Javadi S, Szklaruk J, Bhosale P. Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings. Abdom Radiol (NY) 45(11):3662-3680, 2020. e-Pub 2020. PMID: 32417933.
- Szklaruk J, Son JB, Starr BF, Sun J, Davila A, Bhosale PR, Ma J. Evaluation of feasibility and image quality of a new radial quantitative T2 weighted imaging sequence for liver MRI. Clin Imaging 66:77-81, 2020. e-Pub 2020. PMID: 32460150.
- Slagowski JM, Ding Y, Aima M, Wen Z, Fuller CD, Chung C, Debnam JM, Hwang KP, Kadbi M, Szklaruk J, Wang J. A modular phantom and software to characterize 3D geometric distortion in MRI. Phys Med Biol 65(19):195008, 2020. e-Pub 2020. PMID: 32531763.
- Bathala TK, Venkatesan AM, Ma J, Bhosale P, Wei W, Kudchadker RJ, Wang J, Anscher MS, Tang C, Bruno TL, Frank SJ, Szklaruk J. Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy. Brachytherapy 19(4):484-490, 2020. e-Pub 2020. PMID: 32402544.
- Moawad AW, Szklaruk J, Lall C, Blair KJ, Kaseb AO, Kamath A, Rohren SA, Elsayes KM. Angiogenesis in hepatocellular carcinoma; pathophysiology, targeted therapy, and role of imaging. J Hepatocell Carcinoma(7):77-89, 2020. e-Pub 2020. PMID: 32426302.
- Moawad AW, Fuentes D, Khalaf AM, Blair KJ, Szklaruk J, Qayyum A, Hazle JD, Elsayes KM. Feasibility of automated volumetric assessment of large hepatocellular carcinomas' responses to transarterial chemoembolization. Front Oncol 10:572, 2020. e-Pub 2020. PMID: 32457831.
- Moawad AW, Elsayes KM, Benamar F, Rao K, Sun J, Szklaruk J. Value of follow-up chest computed tomography in the surveillance of patients with hepatocellular carcinoma. J Hepatocell Carcinoma 7:331-335, 2020. e-Pub 2020. PMID: 33240826.
- Szklaruk J, Son JB, Wei W, Bhosale P, Javadi S, Ma J. Comparison of free breathing and respiratory triggered diffusion-weighted imaging sequences for liver imaging. World J Radiol 11(11):134-143, 2019. PMID: 31798795.
- Fuentes D, Ahmed K, Lin JS, Abdel-Wahab R, Kaseb AO, Hassan M, Szklaruk J, Morshid A, Hazle JD, Qayyum A, Elsayes KM. Automated volumetric assessment of hepatocellular carcinoma response to sorafenib: A pilot study. J Comput Assist Tomogr 43(3):499-506, 2019. PMID: 31082956.
- Yacoub JH, Elsayes KM, Fowler KJ, Hecht EM, Mitchell DG, Santillan C, Szklaruk J. Pitfalls in liver MRI: technical approach to avoiding misdiagnosis and improving image quality. J Magn Reson Imaging 49(1):41-58, 2019. e-Pub 2018. PMID: 30295343.
- Elsayes KM, Kielar AZ, Elmohr MM, Chernyak V, Masch WR, Furlan A, Marks RM, Cruite I, Fowler KJ, Tang A, Bashir MR, Hecht EM, Kamaya A, Jambhekar K, Kamath A, Arora S, Bijan B, Ash R, Kassam Z, Chaudhry H, McGahan JP, Yacoub JH, McInnes M, Fung AW, Shanbhogue K, Lee J, Deshmukh S, Horvat N, Mitchell DG, Do RKG, Surabhi VR, Szklaruk J, Sirlin CB. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI. Abdom Radiol (NY) 43(10):2625-2642, 2018. e-Pub 2018. PMID: 30155697.
- Elsayes KM, Menias CO, Morshid AI, Shaaban AM, Fowler KJ, Tang A, Chernyak V, Szklaruk J, Bashir MR. Spectrum of pitfalls, pseudolesions, and misdiagnoses in noncirrhotic liver. AJR Am J Roentgenol 211(1):97-108, 2018. PMID: 29932762.
- Ganeshan D, Szklaruk J, Kaseb A, Kattan A, Elsayes KM. Fibrolamellar hepatocellular carcinoma: multiphasic CT features of the primary tumor on pre-therapy CT and pattern of distant metastases. Abdom Radiol (NY) 43(12):3340-3348. e-Pub 2018. PMID: 29948061.
- Yam C, Murthy RK, Valero V, Szklaruk J, Shroff GS, Stalzer CJ, Buzdar AU, Murray JL, Yang W, Hortobagyi GN, Moulder SL, Arun B. A phase II study of tipifarnib and gemcitabine in metastatic breast cancer. Invest New Drugs 36(2):299-306, 2018. e-Pub 2018. PMID: 29374384.
- Vu LN, Morelli JN, Szklaruk J. Basic MRI for the liver oncologists and surgeons. J Hepatocell Carcinoma 5:37-50, 2018. e-Pub 2018. PMID: 29692983.
- Szklaruk J, Kaya D, Wei W. Evaluation of the added value of imaging the pelvis in patients with hepatocellular cancer. J Gastroenterol Hepatol 33(2):500-502, 2018. e-Pub 2017. PMID: 28612991.
- Szklaruk J, Luersen G, Ma J, Wei W, Underwood M. Gd-EOB-DTPA based magnetic resonance imaging for predicting liver response to portal vein embolization. World J Radiol 9(4):199-205, 2017. PMID: 28529683.
- Zurstrassen CE, Bitencourt AGV, Guimaraes MD, Cavalcante ACBS, Tyng CJ, Amoedo MK, Matsushita Junior JPK, Szklaruk J, Marchiori E, Chojniak R. Percutaneous stent placement for the treatment of malignant biliary obstruction: Nitinol versus elgiloy stents. Radiol Bras 50(2):97-102, 2017. e-Pub 2017. PMID: 28428652.
- Jensen CT, Telesmanich ME, Wagner-Bartak NA, Liu X, Rong J, Szklaruk J, Qayyum A, Wei W, Chandler AG, Tamm EP. Evaluation of abdominal computed tomography image quality using a new version of vendor-specific model-based iterative reconstruction. J Comput Assist Tomogr 41(1):67-74, 2017. e-Pub 2016. PMID: 27529683.
- Elsayes KM, Kielar AZ, Agrons MM, Szklaruk J, Tang A, Bashir MR, Mitchell DG, Do RK, Fowler KJ, Chernyak V, Sirlin CB. Liver imaging reporting and data system: an expert consensus statement. J Hepatocell Carcinoma 4:29-39, 2017. e-Pub 2017. PMID: 28255543.
- Luersen GF, Wei W, Tamm EP, Bhosale PR, Szklaruk J. Evaluation of Magnetic Resonance (MR) biomarkers for assessment of response with response evaluation criteria in solid tumors: comparison of the measurements of neuroendocrine tumor liver metastases (NETLM) with various MR sequences and at multiple phases of contrast administration. J Comput Assist Tomogr 40(5):717-22, 2016. PMID: 27636124.
- Yedururi S, Kang HC, Wei W, Wagner-Bartak NA, Marcal LP, Stafford RJ, Willis BJ, Szklaruk J. Free-breathing radial volumetric interpolated breath-hold examination vs breath-hold cartesian volumetric interpolated breath-hold examination magnetic resonance imaging of the liver at 1.5T. World J Radiol 8(7):707-15, 2016. PMID: 27551341.
- Lim TY, Kudchadker RJ, Wang J, Bathala T, Szklaruk J, Pugh TJ, Mahmood U, Ibbott GS, Frank SJ. Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: Initial patient experience. J Contemp Brachytherapy 8(3):235-42, 2016. e-Pub 2016. PMID: 27504133.
- Morani AC, Vicens RA, Wei W, Gupta S, Vikram R, Balachandran A, Reed BJ, Ma J, Qayyum A, Szklaruk J. CAIPIRINHA-VIBE and GRAPPA-VIBE for liver MRI at 1.5 T: a comparative in vivo patient study. J Comput Assist Tomogr 39(2):263-9, 2015. PMID: 25635931.
- Luersen GF, Bhosale P, Szklaruk J. State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization. J Hepatocell Carcinoma 2:101-17, 2015. e-Pub 2015. PMID: 27508199.
- Faria SC, Szklaruk J, Kaseb AO, Hassabo HM, Elsayes KM. TNM/Okuda/Barcelona/UNOS/CLIP international multidisciplinary classification of hepatocellular carcinoma: concepts, perspectives, and radiologic implications. Abdom Imaging 39(5):1070-87, 2014. e-Pub 2014. PMID: 24695938.
- Ganeshan D, Szklaruk J, Kundra V, Kaseb A, Rashid A, Elsayes KM, Elsayes K. Imaging features of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol 202(3):544-52, 2014. PMID: 24555590.
- Testa ML, Chojniak R, Sene LS, Damascena AS, Guimarães MD, Szklaruk J, Marchiori E. Is DWI/ADC a useful tool in the characterization of focal hepatic lesions suspected of malignancy?. PLoS One 9(7):e101944, 2014. e-Pub 2014. PMID: 25025151.
- Neperud J, Mahvash A, Garg N, Murthy R, Szklaruk J. Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy?. World J Radiol 5(6):241-7, 2013. PMID: 23807902.
- Morani AC, Elsayes KM, Liu PS, Weadock WJ, Szklaruk J, Dillman JR, Khan A, Chenevert TL, Hussain HK. Abdominal applications of diffusion-weighted magnetic resonance imaging: where do we stand?. World J Radiol 5(3):68-80, 2013. PMID: 23671743.
- Le, O, Bhosale, P, Szklaruk J, Ng, C, Tamm, E.. MDCT: impact of new technologies on oncologic imaging – practical considerations. Applied Radiology 42(1):24-34, 2013.
- Ganeshan DM, Szklaruk J. Portal vein embolization: cross sectional imaging of normal features and complications. AJR Am J Roentgenol 199(6):1275-82, 2012. PMID: 23169719.
- Tamm EP, Szklaruk J, Puthooran L, Stone D, Stevens BL, Modaro C. Quality initiatives: planning, setting up, and carrying out radiology process improvement projects. Radiographics 32(5):1529-42, 2012. e-Pub 2012. PMID: 22745219.
- Ganeshan D, Moron FE, Szklaruk J. Extrahepatic biliary cancer: new staging classification. World J Radiol 4(8):345-52, 2012. PMID: 22937214.
- Patnana M, Bronstein Y, Szklaruk J, Bedi DG, Hwu WJ, Gershenwald JE, Prieto VG, Ng CS. Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma. Clin Radiol 66(3):224-236, 2011. PMID: 21295201.
- Merkle EM, Szklaruk J, Taouli B. Imaging techniques in the diagnosis of hepatocellular carcinoma and metastatic carcinoma as a result of colon cancer. Gastroenterol Hepatol (N Y) 6(8):1-16, 2010. PMID: 21475387.
- Bhosale P, Gadre S, Medeiros LJ, Szklaruk J. Extramedullary hematopoiesis mimicking hepatocellular carcinoma. Appl Radiol 39(11):59-60, 2010.
- Bhosale P, Szklaruk J, Iyer R. Multimodality imaging of usual and unusual sites of metastasis which occur after definitive therapy for rectal cancer. Clin Imaging 34(2):100-108, 2010. PMID: 20189072.
- Ozkan E, Balachandran A, Bhosale PR, Tamm EP, Marcal LP, Szklaruk J. Pictorial essay: multimodality imaging of metastases from pancreatic ductal adenocarcinoma. Clin Imaging 34(4):277-287, 2010. PMID: 20630340.
- Le-Petross H, Kundra V, Szklaruk J, Wei W, Hortobagyi GN, Ma J. Fast three-dimensional dual echo Dixon technique improves fat suppression in breast MRI. J Magn Reson Imaging 31(4):889-894, 2010. PMID: 20373433.
- Maniam S, Szklaruk J. Magnetic resonance imaging: review of imaging techniques and overview of liver imaging. World J Radiol 2(8):309-322, 2010. PMID: 21160685.
- Asran M, Rashid A, Szklaruk J. Hepatic endometriosis mimicking metastatic disease: a case report and review of the literature. J Radiol Case Rep 4(11):26-31, 2010. e-Pub 2010. PMID: 22470699.
- Bhosale P, Ma J, Balachandran A, Szklaruk J, Choi H. Utility of the FIESTA pulse sequence in body oncologic imaging: self-assessment module. AJR Am J Roentgenol 192:S94 - S97, 2009.
- Kobayashi K, Szklaruk J, Trent JC, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME, Gupta S. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors. Am J Clin Oncol 32(6):574-581, 2009. PMID: 19636238.
- Tamm EP, Balachandran A, Bhosale P, Szklaruk J. Three-D techniques showcases the pancreas and biliary tree. Diagn Imaging 30(2):S6-S9, 2008.
- Bhosale PR, Patnana M, Viswanathan C, Szklaruk J. The inguinal canal: anatomy and imaging features of common and uncommon masses. Radiographics 28(3):819-835, 2008. PMID: 18480486.
- Beddar AS, Briere TM, Balter P, Pan T, Tolani N, Ng C, Szklaruk J, Krishnan S. 4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning. Radiother Oncol 87(3):445-448, 2008. e-Pub 2008. PMID: 18194819.
- Borghero Y, Crane CH, Szklaruk J, Oyarzo M, Curley S, Pisters PW, Evans D, Abdalla EK, Thomas MB, Das P, Wistuba II, Krishnan S, Vauthey JN. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol 15(11):3147-3156, 2008. PMID: 18754070.
- Morón FE, Szklaruk J. Learning the nodal stations in the abdomen. Br J Radiol 80(958):841-848, 2007. PMID: 17959923.
- Yao JC, Zhang JX, Rashid A, Yeung SC, Szklaruk J, Hess K, Xie K, Ellis L, Abbruzzese JL, Ajani JA. Clinical and in vitro studies of imatinib in advanced carcinoid tumors. Clin Cancer Res 13(1):234-240, 2007. PMID: 17200360.
- Szklaruk J, Bhosale P. Hepatocellular carcinoma: MRI and CT examination. Isr Med Assoc J 9(3):153-155, 2007. PMID: 17402324.
- Mehta S, Szklaruk J, Faria SC, Raymond AK, Whitman GJ. Radiologic-pathologic conferences of the University of Texas MD Anderson Cancer Center: chondromyxoid fibroma of the sacrum and left iliac bone. AJR Am J Roentgenol 186(2):467-469, 2006. PMID: 16423954.
- Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace MJ, Cohen A, Coldwell DM, Kennedy AS, Hicks ME. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S41-S56, 2005. PMID: 16227496.
- Murthy R, Xiong H, Nunez R, Cohen AC, Barron B, Szklaruk J, Madoff DC, Gupta S, Wallace MJ, Ahrar K, Hicks ME. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: Preliminary results. J Vasc Interv Radiol 16(7):937-945, 2005. PMID: 16002501.
- Faria SC, Tamm EP, Varavithya V, Phongkitkarun S, Kaur H, Szklaruk J, Dubrow R, Charnsangavej C. Systematic approach to the analysis of cross-sectional imaging for surveillance of recurrent colorectal cancer. Eur J Radiol 53(3):387-396, 2005. PMID: 15741012.
- Khatti S, Faria SC, Medeiros LJ, Szklaruk J. Myeloid sarcoma of the appendix mimicking acute appendicitis. AJR Am J Roentgenol 182(5):1194, 2004. PMID: 15100117.
- Szklaruk J, Tamm EP, Choi H, Varavithya V. MR imaging of common and uncommon large pelvic masses. Radiographics 23(2):403-424, 2003. PMID: 12640156.
- Szklaruk J, Silverman PM, Charnsangavej C. Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. AJR Am J Roentgenol 180(2):441-454, 2003. PMID: 12540450.
- Silverman PM, Szklaruk J, Tamm EP. Contrast usage for liver imaging in the era of multislice (MSCT), multidetector (MDCT) CT: part II. Appl Radiol 32(6):26-34, 2003.
- Silverman PM, Szklaruk J, Tamm EP. Contrast usage for liver imaging in the era of multislice (MSCT), multidetector (MDCT) CT: part I. Appl Radiol 32(5):30-36, 2003.
- Szklaruk J, Tamm E, Charnsangavej C. Preoperative imaging of biliary tract cancers. Surg Oncol Clin N Am 11(4):865-876, 2002. PMID: 12607576.
- Szklaruk J, Tamm EP, Silverman PM. Radiological case of the month: leiomyosarcoma of the small bowel: a secondary primary tumor in a patient with Wilms' tumor. Appl Radiol 30(6):40-42, 2001.
- Tamm E, Charnsangavej C, Szklaruk J. Advanced 3-D imaging for the evaluation of pancreatic cancer with multidetector CT. Int J Gastrointest Cancer 30(1-2):65-71, 2001. PMID: 12489581.
- Ito K, Mitchell DG, Outwater EK, Szklaruk J, Sadek AG. Hepatic lesions: discrimination of nonsolid, benign lesions from solid, malignant lesions with heavily T2-weighted fast spin-echo MR imaging. Radiology 204(3):729-737, 1997. PMID: 9280251.
- Ito K, Mitchell DG, Outwater EK, Szklaruk J, Sadek AG. Nonsolid benign versus malignant hepatic lesions: discrimination by heavily T2 weighted fast spin echo and multiphasic contrast enhanced dynamic MR imaging. Radiology 205:1542, 1997.
- Blum H, Szklaruk J, Wang DJ, Johnson RG Jr. NMR measurements of the membrane potential in erythrocytes from the partition of tetraphenylphosphonium ion. Biophysics J 57(2):232, 1990.
- Szklaruk J, Marecek JF, Springer AL, Springer CS. Aqueous shift reagents for high-resolution cation NMR spectroscopy. 4. [o-Bis((3-tripolyphosphato)propyloxy)benzene(-)]dysprosate(5-). Inorg Chem 29(4):660-667, 1990.
- Fang AM, Gress JR, Pettaway CA, Ma J, Szklaruk J, Bathala TK, Surasi DS, Chapin BF. Whole-body magnetic resonance imaging for staging prostate cancer: A narrative review. BJU Int.
Invited Articles
- Cher T, Szklaruk J. MR contrast agents: applications in hepatobiliary imaging. Appl Radiol 39(11):26-42, 2010.
- Szklaruk J. Gadolinium-enhanced imaging to identify metastatic lesions. Gastroenterol Hepato 6(8, s14):9-12, 2010.
- Tamm EP, Balachandran A, Bhosale P, Szklaruk J. Update on 3D and multiplanar MDCT in the assessment of biliary and pancreatic pathology. Abdom Imaging 34(1):64-74, 2009. PMID: 18483805.
- Szklaruk J. Recent developments in magnetic resonance imaging of the liver. Gastroenterol Hepato 5:38-43, 2009.
- Bhosale P, Szklaruk J, Silverman PM. Current staging of hepatocellular carcinoma: Imaging implications. Review. Cancer Imaging 4(6):83-94, 2006. PMID: 16829469.
- Szklaruk J. Tomografía computada (MSCT) y resonacia magnética (MRI) en cancer de hígado / multislice computer tomography (MSCT) and magnetic resonance imaging (MRI) of biliary cancer. Oncol Clin Argentina 11(1):1241-1242, 2006.
- Oto A, Tamm EP, Szklaruk J. Multidetector row CT of the liver. Radiol Clin North Am 43(5):827-848, vii, 2005. PMID: 16098342.
- Devine C, Szklaruk J, Tamm EP. Magnetic resonance imaging in the characterization of pelvic masses. Semin Ultrasound CT MR 26(3):172-204, 2005. PMID: 15987066.
- Szklaruk J. 3T MR offering new currency for oncology applications?. Innov in Imaging 20(suppl 3):S14-S16, 2005.
- Silverman PM, Szklaruk J. Controversies in imaging of hepatocellular carcinoma: multidetector CT (MDCT). Cancer Imaging 10(5):178-187, 2005. PMID: 16361147.
- Faria SC, Tamm EP, Loyer EM, Szklaruk J, Choi H, Charnsangavej C. Diagnosis and staging of pancreatic tumors. Semin Roentgenol 39(3):397-411, 2004. PMID: 15372753.
- Szklaruk J, Silverman P. Optimal contrast strategies for detection and staging using multislice CT. Decisions Imaging Econ 17(8):35-38, 2004.
- Szklaruk J, Silverman P. Evaluation of the biliary cancer: clinical imaging approach in the era of multislice CT (MSCT). CT Update, 2003.
- Szklaruk J, Silverman P. Evaluation of hepatocellular carcinoma: clinical imaging approach in the era of multislice CT (MSCT). CT Update, 2002.
Manuals, Teaching Aids, Other Teaching Publications
- . MRI Video the patient experience video for patients scheduled for an MR examination, 2014.
- Bhosale P, Ma J, Balachandran A, Szklaruk J, Choi H. Utility of the FIESTA pulse sequence in body oncologic imaging: self-assessment module. American Roentgen Ray Society.
- Szklaruk J, Tamm EP, Choi H, Varavithya V. Self-Assessment Module: MR imaging of common and uncommon large pelvic masses. Radiological Society of North America.
- Szklaruk J. Indications for pre-medication for patients receiving intravenous contrast agents. Internal Publication, 2000.
- Szklaruk J. Synthesis, characterization and applications of complexes to be used as shift reagents for cation nuclear magnetic resonance studies. Dissertation Abstract International, 1989.
- Springer CS, Chu SC, Rooney WR, Szklaruk J. Bulk magnetic resonance susceptibility forever. In: Texas A&M Newsletter, 1986.
- Muir MM, Szklaruk J, Fernandez SC. Cleave reactions of binuclear complexes of Rhodium (III) and Iridium (III) inorganic chemistry towards the 21st century. In: American Chemical Society Symposium Series M. H. Chisholm, (ed.), 1983.
Editorials
- Murthy R, Szklaruk J. MR angiography of tumor related vasculature: from clinic to the micro-environment - commentary. Radiographics 25(Suppl 1):S97-S98, 2005.
Abstracts
- Ganeshan D, Iyer R, Szklaruk J, Naik S, Bhosale P. Primary renal malignancies beyond clear cell carcinoma: review of select aggressive renal neoplasms, with emphasis on CT and MR. 123rd Annual Meeting of the American Roentgen Ray Society. e-Pub 2023.
- Saleh M, Javadi S, Mathew M, Son JB, Sun J, Bayram E, Wang X, Ma J, Szklaruk J, Bhosale P. T2-weighted pelvic MR imaging using PROPELLER with deep learning reconstruction for improved motion robustness. 2021 International Society for Magnetic Resonance in Medicine & Scientific Meeting and International Society for MR Radiographers & Technologists Exhibition, 2021.
- Wang X, Son JB, Bhosale P, Qayyum A, Ibarra-Rovira JJ, Hwang KP, Stafford J, Pagel MD, Level M, Bayram E, Ma J, Szklaruk J. High resolution prostate T2-weighted MRI with deep learning and without an endorectal coil. 2020 International Society for Magnetic Resonance in Medicine & Scientific Meeting and International Society for MR Radiographers & Technologists Exhibition, 2020.
- Moawad AW, Blair KJ, Shaaban AM, Menias CO, Lall CG, Morani AC, Szklaruk J, Elsayes KM. Current concepts in angiogenesis in solid tumors: pathophysiology, targeted therapy, and complications with multi-modality imaging patterns. 105th Scientific Assembly and Annual Meeting Radiological Society of North America. e-Pub 2019.
- Aima A, Slagowski JM, Ding Y, Vedam S, Yang J, Hwang K, Szklaruk J, Choi S, Fuller CD, Chung C, Wang J. Evaluation of the geometric distortion in clinical MR sequences for a 1.5T MR-linac system. Int J Radiat Oncol Biol Phys 105(1, Supplement):E684-E685, 2019.
- Sanders J, Frank S, Venkatesan A, Bathala T, Szklaruk J, Blanchard P, Kudchadker R, Ma J. TrueFISP for single sequence MR-only post-implant dosimetry of prostate brachytherapy. Med Phys 44(6):3049, 2017. e-Pub 2017.
- Elsayes KM, Arbor A, Szklaruk J, Cynwyd B, Baron RL. Focal hepatic lesions; pitfalls, pseudolesions and misdiagnoses. 102nd Annual Meeting - Radiological Society of North America, 2016.
- Luersen G, Wei W, Bhosale PR, Tamm EP, Szklaruk J. Comparison of the measurements of neuroendocrine tumor liver metastases (NETLM) with various MR sequences and at multiple phases of contrast administration: assessment of RECIST measurements. Society of Abdominal Radiologists 2016 Annual Scientific Meeting and Educational Course, 2016.
- Khan AA, Vicens-Rodriguez, R, Elsayes, KM, Stafford, R, Ahmed, K, Szklaruk, J. Diffusion weighted imaging of the liver: artifacts and pitfalls. Society of Computed Body Tomography & Magnetic Resonance 37th Annual Course, 2014.
- Ballester G, Szklaruk J. Magnetic resonance imaging with Gd-EOB-DTPA: extrahepatic pathology. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2013.
- Ballester G, Llorens C, Tamm E, Moron F, Szklaruk J. Gastrointestinal carcinoid tumor: the role of CT and MR. Society of Computed Body Tomography & Magnetic Resonance 36th Annual Course, 2013.
- Ballester G, Moron F, Szklaruk J. Scoring and staging of renal cell cancers: the role of CT and MR. Society of Computed Body Tomography & Magnetic Resonance 36th Annual Course, 2013.
- Szklaruk J. Qualitative comparative analysis of MR sequences for the evaluation of renal cancer. European Congress of Radiology, 2013.
- Tamm E, Bhosale P, Wagner-Bartak N, Le O, Szklaruk J , Kundra V. An introduction to using dual-energy CT for imaging of pancreatic and hepatic oncology. 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Radiological Society of North America, 2012.
- Szklaruk J, Moron F. Radiological evaluation of patients with HCC: MRI and MSCT. Tumor Biology 33(Suppl 1):29, 2012.
- Faria SC, Elsayes K, Szklaruk J. The role of imaging in the various staging criteria for HCC. The Society of Computed Body Tomography and Magnetic Resonance, 2012.
- Faria S, Szklaruk J, Kaseb A, Elsayes KM. AJCC/Okuda/Barcelona/UNOS/CLIP international multidisciplinary classification of hepatocellular carcinoma: novel concepts, perspectives, and radiologic implications. 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2012.
- Ganeshan D, Szklaruk J, Kundra V, Kaseb A, Rashid A, Elsayes KM. Cytogenetic, histologic and imaging features of fibrolamellar hepatocellular carcinoma: implications for staging diagnosis and. 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2012.
- Wagner-Bartak N, Marcal L, Garg N, Szklaruk J,. Imaging of extrahepatic bile duct cancer: implications of the revised American Joint Committee on Cancer staging classification. AJR Am J Roentgenol 196(5 Suppl):A149, 2011.
- Le-Petross H, Kundra V, Szklaruk J, Wei W, Andreopoulou E, Ma J. Fat suppression for breast MRI improves by fast 3D dual echo Dixon technique. 109th Annual Meeting of the American Roentgen Ray Society 192(5):A79-A86, 2009.
- Bhosale P, Patnana M, Viswanathan C, Szklaruk J. The inguinal canal: anatomy and imaging features of common and uncommon masses-computer exhibit. 92nd Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2006.
- Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace MJ, Cohen A, Coldwell DM, Kennedy AS, Hicks ME. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25(SPEC.ISS):S41-S55, 2005.
- Yao JC, Charnsangavej C, Faria SC, Szklaruk J, Chen H, Hoff P, Phan A, Yeung SCJ, Abbruzzese JL, Ajani JA. Rapid decrease in blood flow (BF), blood volume (BV) and vascular permeability (PS) in carcinoid patients treated with bevacizumab. J Clin Oncol 22(14s):3013, 2004.
- Szklaruk J, Mitchell DG, Outwater EK. Comparison of the efficacy of FSE and fast STIR for the detection of liver lesions. Annual Meeting of the Association of University Radiologists 4(12):847, 1997.
Book Chapters
- Sagebiel T, Szklaruk J. Overview of CT MRI techniques of the liver. In: Cross-Sectional Imaging of the Abdomen and Pelvis, 1-10, 2015.
- Ortiz-Ballester G, Marcal L, Viswanathan C, Szklaruk J. Computed tomography. In: Biliary Tract and Gallbladder Cancer: Diagnosis & Therapy. 2nd Edition. Demos Medical: New York, NY, 2014.
- Morón FE, Delumpa A, Szklaruk J. Spinal Neoplasms. In: CT and MRI of the Whole Body 6E. Eds Boll DT, Haaga J, Castillo M, et al Elsevier Inc, 2014.
- Szklaruk J, Abdalla EK, Krishnan S, Kaseb A, Javle M. Liver cancer: Hepatocellular and fibrolamellar hepatocellular carcinoma. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier: Philadelphia, 95-120, 2012.
- Szklaruk J, Javle M, Abdalla EK, Marcal L, Krishnan S. Cholangiocarcinoma. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier: Philadelphia, 121-152, 2012.
- Marcal LP, Viswanathan C, Szklaruk J. Computed tomography. In: Biliary Tract and Gallbladder Cancer: Diagnosis & Therapy. Demos Medical Publishing: New York, 141-166, 2009.
- Szklaruk J, Silverman PM, Tamm EP. Hepatocellular carcinoma. In: Taveras and Perrucci's Radiology. Wolters Kluwer Health: Philadelphia, 2004.
- Tamm EP, Szklaruk J, Loyer E, Faria SC, Charnsangavej C. Radiographic imaging: CT/MR/PET. In: Pancreatic Cancer. 1st Edition. Jones and Bartlett: United States, 165-180, 2004.
- Wang MX, Sagebiel T, Kamath A, Lee JT, Shehata MA, Szklaruk J. Overview of CT and MRI Techniques of the Liver. In: Practical Approach to Liver Imaging.
Books (edited and written)
- Szklaruk J. Synthesis, characterization, and application of complexes to be used as shift reagents for cation nuclear magnetic resonance studies. In: Thesis (Ph.D). State University of New York at Stony Brook, 1989.
- Szklaruk J. Section Editor: Oncologic imaging for the practicing radiologist, medical oncologist and surgeon. In: Liver, Biliary Tract, and Pancreas. Elsevier.
Grant & Contract Support
Title: | Functional CT for monitoring antiangiogenic effects of Gleevec for patients with metastatic carcinoid tumors |
Funding Source: | Novartis |
Role: | Principal Investigator |
Title: | Prospective non-randomized (pharmacoepidemiologic) cohort study (open-label, multicenter) to assess the magnitude of potential risk with the administration of Primovist/Eovist in patients with moderate to severe renal impairment for the development of nephrogenic systemic fibrosis (NSF) based on diagnostically specific clinical and histopathologic information |
Funding Source: | Bayer Healthcare AG |
Role: | Principal Investigator |
Title: | Prospective non-randomized observational (pharmacoepidemiologic) cohort study (open-label, multicenter) to assess the magnitude of potential risk with the administration of Magnevist® Injection in patients with moderate to severe renal impairment for the development of nephrogenic systemic fibrosis (NSF) based on diagnostically specific clinical and histopathologic information |
Funding Source: | Bayer Healthcare AG |
Role: | Principal Investigator |
Title: | Evaluation of Gd-EOB-DTPA MR Imaging as a prediction of compensatory hypertrophy of the liver following portal vein embolization (PVE) |
Funding Source: | Diagnostic Imaging Clinical Research Committee |
Role: | Principal Investigator |
Title: | Quantitative diffusion MRI for evaluating response to chemotherapy in colorectal liver metastases |
Funding Source: | Society of Abdominal Radiology |
Role: | Significant Contributor |
Title: | Development and validation of an imaging-based deep learning neural network model to predict tumor-related liver failure in unresectable intrahepatic cholangiocarcinoma |
Funding Source: | Radiological Society of North America (RSNA) |
Role: | Co-Investigator |
Title: | Automation of a tumor growth rate measurement to assess immunotherapy response |
Funding Source: | UT MD Anderson QIAC Partnership in Research Program |
Role: | Principal Investigator |
Patient Reviews
CV information above last modified August 29, 2024